» Articles » PMID: 35958129

Untargeted Metabolomics Sheds Light on the Secondary Metabolism of Fungi Triggered by Choline-Based Ionic Liquids

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2022 Aug 12
PMID 35958129
Authors
Affiliations
Soon will be listed here.
Abstract

Fungal secondary metabolites constitute a rich source of yet undiscovered bioactive compounds. Their production is often silent under standard laboratory conditions, but the production of some compounds can be triggered simply by altering the cultivation conditions. The usage of an organic salt - ionic liquid - as growth medium supplement can greatly impact the biosynthesis of secondary metabolites, leading to higher diversity of compounds accumulating extracellularly. This study examines if such supplements, specifically cholinium-based ionic liquids, can support the discovery of bioactive secondary metabolites across three model species: , and . Enriched organic extracts obtained from medium supernatant revealed high diversity in metabolites. The supplementation led apparently to increased levels of either 1-aminocyclopropane-1-carboxylate or α-aminoisobutyric acid. The extracts where bioactive against two major foodborne bacterial strains: and . In particular, those retrieved from cultures showed greater bactericidal potential compared to control extracts derived from non-supplemented cultures. An untargeted mass spectrometry analysis using the Global Natural Product Social Molecular Networking tool enabled to capture the chemical diversity driven by the ionic liquid stimuli. Diverse macrolides, among other compounds, were putatively associated with ; whereas an unexpected richness of cyclic (depsi)peptides with . Further studies are required to understand if the identified peptides are the major players of the bioactivity of extracts, and to decode their biosynthesis pathways as well.

Citing Articles

Discovering New Natural Products Using Metabolomics-Based Approaches.

de Medeiros L, de Araujo Junior M, Peres E, Carlos Ipuchima da Silva J, Bassicheto M, Di Gioia G Adv Exp Med Biol. 2023; 1439:185-224.

PMID: 37843810 DOI: 10.1007/978-3-031-41741-2_8.


Molecular regulation of fungal secondary metabolism.

Yu W, Pei R, Zhou J, Zeng B, Tu Y, He B World J Microbiol Biotechnol. 2023; 39(8):204.

PMID: 37209190 DOI: 10.1007/s11274-023-03649-6.

References
1.
Stone T, Deber C . Therapeutic design of peptide modulators of protein-protein interactions in membranes. Biochim Biophys Acta Biomembr. 2016; 1859(4):577-585. DOI: 10.1016/j.bbamem.2016.08.013. View

2.
Cacho R, Chooi Y, Zhou H, Tang Y . Complexity generation in fungal polyketide biosynthesis: a spirocycle-forming P450 in the concise pathway to the antifungal drug griseofulvin. ACS Chem Biol. 2013; 8(10):2322-30. PMC: 3821396. DOI: 10.1021/cb400541z. View

3.
Nakao Y, Oku N, Matsunaga S, Fusetani N . Cyclotheonamides E2 and E3, new potent serine protease inhibitors from the marine sponge of the genus Theonella. J Nat Prod. 1998; 61(5):667-70. DOI: 10.1021/np970544n. View

4.
Ding J, Ding Z, Zhao J, Li M, Hu D, Jiang X . A new pregnane steroid from cultures of . Nat Prod Res. 2018; 33(13):1885-1890. DOI: 10.1080/14786419.2018.1478828. View

5.
Portmann C, Blom J, Kaiser M, Brun R, Juttner F, Gademann K . Isolation of aerucyclamides C and D and structure revision of microcyclamide 7806A: heterocyclic ribosomal peptides from Microcystis aeruginosa PCC 7806 and their antiparasite evaluation. J Nat Prod. 2008; 71(11):1891-6. DOI: 10.1021/np800409z. View